Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dalia Ahmed Bassiouny is active.

Publication


Featured researches published by Dalia Ahmed Bassiouny.


Journal of The European Academy of Dermatology and Venereology | 2010

Five-year experience in the treatment of alopecia areata with DPC

Bakr Mohamed El-Zawahry; Dalia Ahmed Bassiouny; A Khella; Naglaa S. Zaki

Background  The effectiveness of Diphencyprone (DPC) in alopecia areata (AA) was demonstrated in several studies with highly variable response rates ranging from 5% to 85%.


Journal of The European Academy of Dermatology and Venereology | 2011

Autologous melanocyte-keratinocyte suspension in the treatment of vitiligo.

Bakr Mohamed El-Zawahry; Naglaa S. Zaki; Dalia Ahmed Bassiouny; Rm Sobhi; A Zaghloul; Mervat M. Khorshied; Heba Gouda

Background  In stable vitiligo, several techniques of autologous transplantation of melanocytes are used. Autologous melanocyte transplantation of non‐cultured melanocytes is one of those techniques with variable reported outcomes.


Photodermatology, Photoimmunology and Photomedicine | 2012

A comparative study on efficacy of UVA1 vs. narrow‐band UVB phototherapy in the treatment of vitiligo

Bakr Mohamed El-Zawahry; Dalia Ahmed Bassiouny; Rehab Mohamed Sobhi; Eman Abdel-Aziz; Naglaa S. Zaki; Dawoud Fakhry Habib; Dalia Mamdouh Shahin

Narrow‐band ultraviolet B (NB‐UVB) is considered the most effective and safe initial treatment for moderate‐to‐severe vitiligo but phototoxicity and possible carcinogenicity are the reported side effects. Ultraviolet A1 (UVA1) phototherapy has overlapping biological effects to NB‐UVB and is relatively free of side effects associated with other phototherapy regimens.


Journal of Cosmetic Dermatology | 2007

Combined trichloroacetic acid peel and topical ascorbic acid versus trichloroacetic acid peel alone in the treatment of melasma: a comparative study.

Mohsen Soliman; Shahira Ramadan; Dalia Ahmed Bassiouny; Marwa Abdelmalek

Background  Melasma is a common acquired hypermelanosis that is difficult to treat. Several chemical peeling agents were used in treatment of melasma. Topical vitamin C was also used with minimal side effects.


Journal of Cosmetic Dermatology | 2015

Ablative CO2 fractional resurfacing in treatment of thermal burn scars: an open-label controlled clinical and histopathological study.

Bakr Mohamed El-Zawahry; Rehab Mohamed Sobhi; Dalia Ahmed Bassiouny; Sahar A. Tabak

Burn scars can cause permanent disfiguring problems with limited treatments available.


Dermatologic Surgery | 2011

Subcision Versus 100% Trichloroacetic Acid in the Treatment of Rolling Acne Scars

Shahira Ramadan; Mohamed El-Komy; Dalia Ahmed Bassiouny; Seham El-Tobshy

BACKGROUND Acne scarring is common but surprisingly difficult to treat. Newer techniques and modifications to older ones may make this refractory problem more manageable. The 100% trichloroacetic acid (TCA) chemical reconstruction of skin scars (CROSS) method is a safe and effective single modality for the treatment of atrophic acne scars, whereas subcision appears to be a safe technique that provides significant improvement for rolling acne scars. OBJECTIVE To compare the effect of the 100% TCA CROSS method with subcision in treating rolling acne scars. METHODS Twenty patients of skin types III and IV with bilateral rolling acne scars received one to three sessions of the 100% TCA CROSS technique for scars on the left side of the face and subcision for scars on the right side. RESULTS The mean decrease in size and depth of scars was significantly greater for the subcision side than the 100% TCA CROSS (p<.001). More side effects in the form of pigmentary alteration were observed with the 100% TCA CROSS method. CONCLUSION For rolling acne scars in patients with Fitzpatrick skin types III and IV, subcision shows better results with fewer side effects than the 100% TCA CROSS technique, although further decrease in scar depth with time occurs more significantly after 100% TCA CROSS. The authors have indicated no significant interest with commercial supporters.


Journal of Dermatological Treatment | 2011

Sulfasalazine and pentoxifylline in psoriasis: A possible safe alternative

Medhat El-Mofty; Mohamed El-Darouti; Hoda Rasheed; Dalia Ahmed Bassiouny; Mona R.E. Abdel-Halim; Naglaa S. Zaki; Ghada M. El-Hanafy; Heba H El-hadidi; Omar A. Azzam; Amany Z. El-Ramly; Marwa M. Fawzy

Abstract Background: Conventional therapy of extensive psoriasis is effective but has complications. Biologics are safer but expensive. Objective: To assess the efficacy of sulfasalazine and pentoxifylline, which have TNF antagonizing and anti-proliferative action in the treatment of psoriasis. Methods: In this randomized controlled trial, 32 patients with extensive psoriasis were divided into four groups: group A received sulfasalazine; group B received pentoxifylline; group C received both drugs; and group D received methotrexate. The Psoriasis Area and Severity Index (PASI) score was done at weeks 0, 2, 4, 6 and 8. Results: A significant reduction in PASI score occurred in groups C and D (p = 0.043 and 0.018, respectively). A significantly higher percentage of PASI score reduction occurred in group D compared with groups A, B and C (p = 0.006, 0.003 and 0.030, respectively). An excellent response occurred in one patient (14.3%) in group D. A very good response occurred in two patients (22.2%) in group C, and in five patients (71.4%) in group D. A moderate response occurred in three patients (37.5%) in group A, one patient (12.5%) in group B, and one patient (14.3%) in group D. Conclusion: Although incomparable to methotrexate, combined sulfasalazine and pentoxifylline produced a good response in cases of extensive psoriasis. Multicentre studies are needed to validate these results.


Pigment Cell & Melanoma Research | 2018

CXCL-10 and Interleukin-6 are Reliable Serum Markers for Vitiligo Activity: A Multicenter Cross-Sectional Study.

Marwa Abdallah; Medhat El-Mofty; Tag S. Anbar; Hoda Rasheed; Samia Esmat; Amira Al‐Tawdy; Marwa M. Fawzy; Dalia M. Abdelhalim; Rehab A. Hegazy; Heba I. Gawdat; Dalia Ahmed Bassiouny; Mona A. Ibrahim; Iman Sany; Mahy El‐Bassiouny; Mohamed Khalil; Abeer Abdel‐Aziz; Zeinab M. El Maadawi; Wedad Z. Mostafa

This cross‐sectional multicenter study aimed to evaluate serum CXCL‐10, as an activity marker for vitiligo, and compare it with other putative serum and tissue markers. Serum CXCL‐10 was compared to interferon gamma (IFN‐γ), interleukin 6 (IL‐6), and IL‐17 using ELISA in 55 non‐segmental vitiligo patients (30 active and 25 stable) and 30 healthy controls. Marginal skin biopsy was taken for immunohistochemical evaluation of CD8+T cells and CXCL‐10+ve cells. Serum levels of CXCL‐10, IL‐17, and IL‐6 were elevated in all vitiligo patients compared to controls (p < .05). All investigated serum markers were higher in active versus stable vitiligo. Tissue expression of CXCL‐10+ve cells and CD8+ve T cells was stronger in vitiligo patients compared to controls, and tissue CXCL‐10+ve cell expression was stronger in active versus stable cases. Positive correlations were noted between the different serum and tissue markers. CXCL‐10 was the most specific, whereas IL‐6 was the most sensitive serum marker to distinguish active from stable disease.


Dermatologic Surgery | 2017

Effect of Procedural-Related Variables on Melanocyte-Keratinocyte Suspension Transplantation in Nonsegmental Stable Vitiligo: A Clinical and Immunocytochemical Study.

Bakr Mohamed El-Zawahry; Samia Esmat; Dalia Ahmed Bassiouny; Naglaa S. Zaki; Rehab Mohamed Sobhi; Marwah A. Saleh; Dalia M. Abdelhalim; Rehab A. Hegazy; Heba I. Gawdat; Nesrin Samir; Marwa El-Hawary; Zeinab M. El Maadawi; Heba Gouda; Mervat M. Khorshied

BACKGROUND Melanocyte–keratinocyte suspension (M–K susp) is gaining popularity for vitiligo treatment. Few studies have addressed procedure-related variables. OBJECTIVE To assess the effect of different M–K susp procedure-related variables on the clinical outcome in stable vitiligo. METHODS This prospective multicenter comparative study included 40 cases with nonsegmental stable vitiligo. Donor site was either a skin graft in noncultured epidermal cell suspension (NCECS) or hair follicle units in outer root sheath hair follicle suspension (ORSHFS). Recipient site was prepared by either cryoblebbing or CO2 laser resurfacing. Cell counts and viability were recorded in the cell suspensions. Tissue melanocytes and keratinocytes were examined by melan-A and cytokeratin, respectively. Assessment of repigmentation was performed 18 months after the procedure. RESULTS Thirty-seven subjects completed the study. Cell count was significantly lower in the ORSHFS compared with NCECS with no significant difference in the repigmentation outcome. On comparing techniques of recipient site preparation, homogenicity was better in the CO2 group. Elbows and knees responded better to CO2 resurfacing, whereas distal fingers responded better to combination of cryoblebbing with NCECS. CONCLUSION Using different techniques in M–K susp produces comparable results. However, the distal fingers showed better results using combination of donor NCECS and recipient cryoblebs.


Dermatology | 2016

Dermoscopic and Immunohistochemical Changes in Acquired Melanocytic Nevi following Narrow-Band Ultraviolet B Therapy

Hesham Zaher; Dalia Ahmed Bassiouny; R Abdel Hay; Nesrin Samir; Nanees Ragab; Safinaz Sayed

Background: Acquired melanocytic nevi (AMN) have been reported to undergo morphological and dermoscopic changes following exposure to narrow-band ultraviolet B (NB-UVB) radiation. Objective: To study the morphological, dermoscopic and immunohistochemical changes in AMN following NB-UVB radiation. Methods: Suberythemogenic NB-UVB sessions were delivered to 40 patients with AMN. For each patient, a minimum of 2 nevi were selected. One nevus was surgically removed from each patient prior to sessions as control; for the other nevus, dermoscopic images were captured before and after NB-UVB sessions. The images were evaluated for changes. At the end, another nevus was surgically removed for immunohistochemical assessment of Ki-67 and melan-A. Results: Our study showed a statistically significant increase in the size of AMN following NB-UVB radiation. Benign dermoscopic changes were observed. Statistically significant positive correlations were found between some dermoscopic findings and the total cumulative dose of NB-UVB. Immunohistochemical analysis did not show any significant change in the exposed AMN. Conclusion: AMN irradiated with repeated suberythemogenic doses of NB-UVB showed benign morphological and dermoscopic changes, and this was confirmed by our immunohistochemical study.

Collaboration


Dive into the Dalia Ahmed Bassiouny's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge